Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
primula veris + hyoscyamus niger
- Development stage
- Unknown
- Lead developer
- Weleda
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Primula veris + hyoscyamus niger is an anthroposophic medicinal combination developed by Weleda AG for the treatment of functional cardiovascular disorders and nervous heart complaints. The formulation leverages the pharmacological properties of two botanical extracts: *Primula veris* (cowslip) and *Hyoscyamus niger* (henbane). *Hyoscyamus niger* contains tropane alkaloids, such as hyoscyamine and scopolamine, which act as non-selective muscarinic acetylcholine receptor antagonists, providing sedative and antispasmodic effects that help alleviate anxiety-induced cardiac symptoms. *Primula veris* is traditionally utilized in anthroposophic medicine to stabilize the rhythmic system and support cardiac function. This combination is typically administered as oral drops to manage symptoms like palpitations, heart racing, and sleep disturbances associated with nervous tension.
- Brand names
- Primula/Hyoscyamus
- Other names
- Primula veris, Flos / Hyoscyamus niger, Herba
02
Targets
mAChR (Muscarinic acetylcholine receptors)
Beyond the preview
Go deeper on primula veris + hyoscyamus niger.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on primula veris + hyoscyamus niger.